Image for illustrative purposes only. Not a real photo.

Amplia halts trial recruitment amidst chemotherapy toxicities

Written by Mahathir BayenaPublished Apr 7, 2026, 12:14 AMLast Updated Jul 6, 2026, 10:30 AM

Amplia Therapeutics (ASX:ATX) announced a shift in its clinical programme, halting further recruitment for the AMPLICITY trial.

More ways to discover